Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 24, 2015 11:40 PM ET

Life Sciences Tools and Services

Company Overview of Albany Molecular Research Inc.

Executive Profile

William S. Marth

Chief Executive Officer, President and Director, Albany Molecular Research Inc.
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 8 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. William S. Marth, also known as Bill, has been the Chief Executive Officer and President of Albany Molecular Research Inc. since January 1, 2014. Mr. Marth served as the Chief Executive Officer and President of Americas for Teva Pharmaceutical Industries Limited from June 2010 to November 5, 2012, and served as its Senior Advisor until December 31, 2013. He served as the Chief Executive Officer and President of TEVA Pharmaceuticals USA, Inc., a division of Teva Pharmaceutical ...

Corporate Headquarters

26 Corporate Circle
Albany, New York 12203

United States

Phone: 518-512-2000
Fax: 518-512-2020

Board Members Memberships

Chief Executive Officer, President and Director
Chairman of The Board, Chairman of Corporate Governance/Nominating Committee, Member of Audit Committee and Member of Compensation Committee
Director and Member of Research & Development Committee


BS 1977
University of Illinois-Urbana-Champaign
MBA 1989
Keller Graduate School of Management

Other Affiliations

Annual Compensation

Total Annual Compensation$982,500

Stocks Options

Restricted Stock Awards$1,767,625
All Other Compensation$14,814
Exercisable Options$22,367
Exercisable Options Value$272,204
Total Value of Options$272,204
Total Number of Options$22,367

Total Compensation

Total Annual Cash Compensation$997,314
Total Short Term Compensation$982,500
Other Long Term Compensation$1,782,439
Total Calculated Compensation$2,764,939

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Steven M. Klosk Chief Executive Officer, President and Director
Cambrex Corporation.
Masayo Tada Chief Executive Officer, President, Executive Director of Drug Development, Representative Director and Chairman of Risk Management Committee
Sumitomo Dainippon Pharma Co., Ltd.
Rudolf Hanko Ph.D.Chief Executive Officer and Member of Executive Committee
Siegfried Holding AG
Daniel J. Abdun-Nabi Chief Executive Officer, President, Director, Member of Strategic Operations Committee and Member of Pricing Committee
Emergent BioSolutions, Inc.
Dayanand Thandalam Sriram Managing Director and Director
GlaxoSmithKline Consumer Nigeria Plc
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Albany Molecular Research Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at